Long-term biomonitoring of breast cancer patients under adjuvant chemotherapy: the comet assay as a possible predictivive factor
Publication date:
2013Publisher version:
http://dx.doi.org/10.1093/mutage/ges050Citación:
Mutagenesis, 28, 1, p. 39-48 (2013); doi:10.1093/mutage/ges050Descripción física:
p. 39-48ISSN:
0267-8357Patrocinado por
This work was financed by MEC (DGES) PB98/1561, FICYT PB-MED01-24 and MCYT BMC2002-00930. E.U. was supported by FICYT and UO Ph.D. grants. The Oncology Institute (Instituto Universitario de Oncología del Principado de Asturias, IUOPA) is supported by Obra Social Cajastur.
Id. Proyecto
MEC/PB98/1561
FICYT/PB-MED01-24
MCYT/BMC2002-00930
Collections
- Artículos [27043]